After a busy first half to 2022, we are pleased to announce that Pitt Street Research has initiated coverage on Wellnex Life Limited (ASX: WNX). The research report provides a good overview of our business model, what we have been able to achieve since re-listing and future potential for the company. Click here to view the research report.
Research highlights
- Valuation range of A$0.253-0.394 per share using DCF approach.
- Health and wellness market is growing rapidly and the company is set to capture the emerging market opportunity.
- Future drivers of growth: GlaxoSmithKline, Chemist Warehouse and Wagner Liquigesics, Pharmacy Own brand, Australian Dairy Nutritionals, Mark Wahlberg’s Performance Inspired brand.
- Believe WNX has significant scope for re-rating over the next few years, if it can meet its potential.
To view the research report click here.
Report link :
https://wellnexlife.investorportal....6/WellnexLiferesearchinitiation17062022-1.pdf
[ATTACH] [ATTACH] After a busy first half to 2022, we are...
Add WNX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
-0.001(3.45%) |
Mkt cap ! $36.10M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.9¢ | 2.7¢ | $33.43K | 1.193M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 698058 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 123136 | 2 |
View Market Depth
| Last trade - 15.57pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.8¢ |
Change
-0.001 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 2.8¢ | 2.8¢ | 2.8¢ | 35749 | ||
| Last updated 14.12pm 05/06/2024 ? | |||||
| WNX (ASX) Chart |